Let-7c Governs the Acquisition of Chemo- or Radioresistance and Epithelial-to-Mesenchymal Transition Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma

MicroRNA (miRNA) expression and functions have been reported to contribute to phenotypic features of tumor cells. Although targets and functional roles for many miRNAs have been described in lung adenocarcinoma (LAD), their pathophysiologic roles in phenotypes of chemoresistant LAD cells are still largely unclear. Previously, docetaxel (DTX)-resistant LAD cell lines (SPC-A1/DTX and H1299/DTX) were established by our laboratory and displayed chemo- or radioresistance and mesenchymal features with enhanced invasiveness and motility. Unbiased miRNA profiling indicated that let-7c (MIRLET7C) was significantly downregulated in SPC-A1/DTX cells. Ectopic let-7c expression increased the in vitro and in vivo chemo- or radiosensitivity of DTX-resistant LAD cells through enhanced apoptosis, reversal of epithelial-to-mesenchymal phenotypes, and inhibition of in vivo metastatic potential via inactivation of Akt phosphorylation, whereas a let-7c inhibitor decreased the chemo- or radiosensitivity of parental cells. Further investigation suggested that let-7c significantly reduced the luciferase activity of a Bcl-xL 3′-UTR-based reporter, concordant with reduced Bcl-xL protein levels. Additionally, siRNA-mediated Bcl-xL knockdown mimicked the same effects of let-7c precursor, and enforced Bcl-xL expression partially rescued the effects of let-7c precursor in DTX-resistant LAD cells. Furthermore, we found that Bcl-xL was significantly upregulated in DTX-nonresponding LAD tissues, and its expression was inversely correlated with let-7c expression. This study suggests an important role for let-7c in the molecular etiology of chemoresistant lung adenocarcinoma. Mol Cancer Res; 11(7); 699–713. ©2013 AACR.

[1]  Jun Luo,et al.  MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth , 2012, PloS one.

[2]  Carlos Agustí,et al.  MicroRNAs Expressed during Lung Cancer Development Are Expressed in Human Pseudoglandular Lung Embryogenesis , 2009, Oncology.

[3]  Kiyoshi Yanagisawa,et al.  Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11‐21 in human lung cancer , 2008, Genes, chromosomes & cancer.

[4]  Jhi-Joung Wang,et al.  Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. , 2011, Oncology reports.

[5]  A. Chang Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. , 2011, Lung cancer.

[6]  C. Dinney,et al.  Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer , 2009, Cancer and Metastasis Reviews.

[7]  Liang-an Chen,et al.  microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (Review) , 2012, Molecular medicine reports.

[8]  J. Minna,et al.  Homozygous deletion scanning of the lung cancer genome at a 100‐kb resolution , 2007, Genes, chromosomes & cancer.

[9]  Hideo Baba,et al.  Epithelial–mesenchymal transition in cancer development and its clinical significance , 2010, Cancer science.

[10]  R. Gatti,et al.  MicroRNAs: new players in the DNA damage response. , 2011, Journal of molecular cell biology.

[11]  W. De,et al.  Identification of ING4 (Inhibitor of Growth 4) as a Modulator of Docetaxel Sensitivity in Human Lung Adenocarcinoma , 2012, Molecular medicine.

[12]  J. Walling Chemotherapy for advanced non-small-cell lung cancer. , 1994, Respiratory medicine.

[13]  S. Gettinger,et al.  A decade of advances in treatment for advanced non-small cell lung cancer. , 2011, Clinics in chest medicine.

[14]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[15]  M. Zern,et al.  Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. , 2011, Journal of hepatology.

[16]  Y. Doki,et al.  The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. , 2010, Journal of hepatology.

[17]  J. Mendell,et al.  MicroRNAs in Stress Signaling and Human Disease , 2012, Cell.

[18]  Feng Bing,et al.  Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1) , 2009, Journal of cellular and molecular medicine.

[19]  Nikitina Eg,et al.  MicroRNAs and human cancer. , 2012 .

[20]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[21]  B. Monia,et al.  Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs. , 2002, Leukemia research.

[22]  Ming Sun,et al.  Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells , 2011, World journal of surgical oncology.

[23]  Huan Yang,et al.  Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer. , 2005, Current opinion in investigational drugs.

[24]  P-C. Yang,et al.  MicroRNA in lung cancer , 2010, British Journal of Cancer.

[25]  J. Gu,et al.  Let‐7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer , 2012, The Journal of pathology.

[26]  N. Matsuura,et al.  Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. , 2011, The Annals of thoracic surgery.

[27]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[28]  F. Slack,et al.  The let-7 family of microRNAs. , 2008, Trends in cell biology.

[29]  Sang-Gu Hwang,et al.  Bcl‐XL and STAT3 mediate malignant actions of γ‐irradiation in lung cancer cells , 2010, Cancer science.

[30]  E. Nikitina,et al.  MicroRNAs and human cancer. , 2012, Experimental oncology.

[31]  Long-Bang Chen,et al.  MicroRNA‐200b reverses chemoresistance of docetaxel‐resistant human lung adenocarcinoma cells by targeting E2F3 , 2012, Cancer.

[32]  Huamin Wang,et al.  Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. , 2009, Cancer research.

[33]  De-Pei Liu,et al.  MicroRNAs: key participants in gene regulatory networks. , 2003, Current opinion in chemical biology.

[34]  Bing Feng,et al.  MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1. , 2012, Cancer letters.

[35]  Margaret S. Ebert,et al.  Roles for MicroRNAs in Conferring Robustness to Biological Processes , 2012, Cell.

[36]  A. Aigner MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs , 2011, Journal of Molecular Medicine.

[37]  S. Qiu,et al.  Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial–mesenchymal transition , 2011, Cancer Gene Therapy.

[38]  Alfonso Bellacosa,et al.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.

[39]  A. Pasquinelli,et al.  Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation , 2005, Cell.

[40]  R. Kim Unknotting the roles of Bcl-2 and Bcl-xL in cell death. , 2005, Biochemical and biophysical research communications.

[41]  Sun-Mi Park,et al.  The role of let-7 in cell differentiation and cancer. , 2010, Endocrine-related cancer.

[42]  Zhiwei Wang,et al.  Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. , 2009, Cancer research.